BMY vs CL · P/E 17, rev $24.46B vs P/E 34, rev $10.69B
Bristol-Myers Squibb Company (BMY) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the BMY and CL stock pages for the full models.
Not investment advice.